SCHEMBL2178767

SCHEMBL2178767

CC(C)C(C(=O)O)N1Cc2ccc(-c3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)cc2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
DGAT1 O75907 5/20 0.45
ALDH1A1 P00352 5/20 0.44
HTT P42858 1/20 0.44
KDR P35968 2/20 0.44
GAA P10253 5/20 0.43
MAPT P10636 5/20 0.42
TDP1 Q9NUW8 4/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
FGFR1 P11362 1/20 0.41
PDGFRA P16234 1/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
CSGALNACT1 Q8TDX6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179086 1.00 THRB (0.46) THRBDGAT1ALDH1A1HTTKDR
SCHEMBL2181755 0.93 DGAT1 (0.49) THRBDGAT1ALDH1A1HTTGAA
SCHEMBL2178008 0.93 DGAT1 (0.49) THRBDGAT1ALDH1A1HTTGAA
SCHEMBL2179431 0.93 KDR (0.52) THRBDGAT1HTTKDRMAPT
SCHEMBL2178379 0.93 KDR (0.52) THRBDGAT1HTTKDRMAPT
SCHEMBL2178373 0.93 KDR (0.52) THRBDGAT1HTTKDRMAPT
SCHEMBL2181156 0.89 PPIA (0.46) THRBDGAT1HTTKDRGAA
SCHEMBL2179260 0.89 PPIA (0.46) THRBDGAT1HTTKDRGAA
SCHEMBL2179028 0.87 SDCBP (0.45) DGAT1ALDH1A1KDRLMNATP53
SCHEMBL2178546 0.86 DGAT1 (0.54) THRBDGAT1HTTKDRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US claimed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US claimed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP claimed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO claimed
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US disclosed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US disclosed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP disclosed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE DGAT1, DGAT2, LCAT THRB 2612/4885DGAT1 1/4885ALDH1A1 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.